Risk of diabetic retinopathy between sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide-1 receptor agonists
doi: 10.1016/S0140-6736(19)31149-3 43 HusainMBirkenfeldALDonsmarkMDunganKEliaschewitzFGFrancoDRet al
The stimulation of the GIP receptor may also promote better post-meal glucose control and improve fat metabolism, which can be especially beneficial for patients struggling with obesity alongside type 2 diabetes
Porque en ltima instancia, esto no se trata nicamente de prdida de peso, sino de preservar funcionalidad, productividad y capacidad cognitiva en una poblacin que envejece
Dual peptides for the treatment of obesity Tirzepatide, a novel dual GIP and GLP-1RA, offers significant insights into its mechanism of action, therapeutic benefits, and clinical applications for the management of T2D and obesity in general practice